THQ: Steady And Reliable Fund

Summary

  • THQ has remained a steady healthcare-related fund to invest in since its inception.
  • The fund provides an attractive and an achievable monthly distribution.
  • Investing in healthcare still makes sense as we aren't in the clear of this pandemic heading into the winter months.
  • This idea was discussed in more depth with members of my private investing community, CEF/ETF Income Laboratory. Get started today »

Written by Nick Ackerman, co-produced by Stanford Chemist

Tekla Healthcare Opportunities Fund (NYSE:THQ) has been providing investors a steady distribution since its inception. This has been the case even through the March market collapse. Healthcare remains a relatively attractive area to invest in while the world deals with the pandemic on a daily basis. The large and stable companies held within THQ represent a stable area to invest in. This leaves one being sheltered from more volatility areas of the market and providing diversification.

(Source)

THQ has an investment objective to "seek current income and long-term capital appreciation." It attempts to achieve this through "a versatile growth and income investment strategy investing across all healthcare sub-sectors and across a company's full capital structure."

For THQ, it primarily invests in common stocks - though convertible and non-convertible notes also represent a meaningful allocation. Additionally, while the emphasis is on "across all healthcare sub-sectors;" the portfolio leans heaviest in pharmaceuticals that can be relatively more defensive. Though healthcare more broadly is defensive in nature due to the comparably stable nature of the business.

The fund is sizeable at just over $1.06 billion in managed assets. Increasing the risk from a comparable ETF is the fact that the fund does utilize leverage. Currently, this comes out to around 21.08% of assets. This is rather low, especially when considering the more stable investments of healthcare. That being said, we did see the damaging effects of leverage during March's selloff, when everything tanked.

The fund's expense ratio comes to 1.49%. When including the leverage expenses, this increases to 2.22%.

Performance - Attractive Returns From A Monthly Dividend CEF

Since its inception, THQ has put up respectable returns. Being involved in the healthcare sector means that it has had to maneuver through political heat on pharmaceutical drug pricing. The

Profitable CEF and ETF income and arbitrage ideas

https://static.seekingalpha.com/uploads/2019/5/2/27546953-15567808556447084.pngAt the CEF/ETF Income Laboratory, we manage ~8%-yielding closed-end fund (CEF) and exchange-traded fund (ETF) portfolios to make income investing easy for you. Check out what our members have to say about our service.

To see all that our exclusive membership has to offer, sign up for a free trial by clicking on the button below!

This article was written by

15.25K Followers

Nick Ackerman is a former financial advisor using his experience to provide coverage on closed-end funds and exchange-traded funds. Nick has previously held Series 7 and Series 66 licenses and has been investing personally for over 14 years.

He contributes to the investing group CEF/ETF Income Laboratory along with leader Stanford Chemist, and Juan de la Hoz and Dividend Seeker. They help members benefit from income and arbitrage strategies in CEFs and ETFs by providing expert-level research. The service includes: managed portfolios targeting safe 8%+ yields, actionable income and arbitrage recommendations, in-depth analysis of CEFs and ETFs, and a friendly community of over a thousand members looking for the best income ideas. These are geared towards both active and passive investors. The vast majority of their holdings are also monthly-payers, which is great for faster compounding as well as smoothing income streams. Learn More.

Analyst’s Disclosure:I am/we are long THQ, UNH. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

About THQ Ticker

SymbolLast Price% Chg
Expense Ratio
Div Frequency
Div Rate
Yield
Assets (AUM)
Volume
Compare to Peers

More on THQ

Related Stocks

SymbolLast Price% Chg
THQ
--